<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20220518054902N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2022-05-28</date_registration>
      <primary_sponsor>Islamic azad university, arak branch</primary_sponsor>
      <public_title>Comparison of the effectiveness of direct electrical brain movement and cognitive-behavioral therapy in executive function and consumption in individuals with substance abuse</public_title>
      <acronym></acronym>
      <scientific_title>Comparison of the effectiveness of direct electrical brain movement and cognitive-behavioral therapy in executive function and consumption in individuals with substance abuse</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2022-05-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>45</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/63630</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: A clinical trial consisting of two control groups and a control group, with parallel, randomized groups, on 45 patients. For random allocation, the block-making method (quadruple blocks) is used. A list of blocks is written and numbers are assigned to them, and finally the treatment allocation list is determined based on random numbers. To do this, a random block sequencing website is used. Random block sequencing is provided to a specific person outside the research team who is responsible for random allocation, Blinding description: Both experimental groups for blinding in 10 sessions, one group participates in cognitive-behavioral therapy sessions and the other group participates in sessions of electrical stimulation of the brain, and the control group does not receive any intervention. Attempts are made to schedule the meetings in such a way that the members of the control and intervention group do not collide with each other and are not informed about the content of each other's meetings. Also, the participant is not aware of the result.</study_design>
      <phase>N/A</phase>
      <hc_freetext>People with a history of substance abuse.</hc_freetext>
      <i_freetext>Intervention 1: Direct electrical stimulation period of the brain: twice a week on Sundays and Thursdays for 5 consecutive weeks as follows. How to hold meetings. The treatment plan will be the same in all 10 sessions of intervention in terms of type, severity and duration of stimulation. During the treatment sessions, the subject will sit on a comfortable chair, then according to the standard system of 10 to 20 electroencephalography reported by Jasper, points will be identified on the subject's head and the anode electrode on the lateral dorsal lateral cortex and the cathode electrode on the lateral dorsal cortex. His right forehead will be placed and applied with a pair of sponge electrodes measuring 3.5 cm of direct current generated by a current of 2 mA with 30 seconds of up and down for 20 minutes. During the stimulation, the subject sits on a chair and does not perform a specific task. Intervention 2: Group cognitive-behavioral therapy will be based on Beck theory's cognitive-behavioral therapy. This intervention will be taught in 10 sessions as follows: Session 1: initial acquaintance and establishing a therapeutic relationship, raising the main complaints of women, brief introduction of the type of treatment, collaborating with the research sample in determining the goals of the treatment protocol, determining the relationship between cognition, Emotion and behavior, choosing goals and identifying goals and agreeing on homework, recording life events. Session 2: Formulation of general problems of addicts in the form of cognitive-behavioral model, integration of cognitive triangle in treatment strategies, use of standard behavioral activation techniques , Redesigning negative spontaneous thoughts and presenting dysfunctional thoughts record sheet. Session 3: Continuing to work with spontaneous thoughts, examining patients' dysfunctional thoughts record sheets, challenging spontaneous thoughts by Socrates method. Session 4: Recognizing underlying beliefs and how to activate them in situations Specifically, the use of downward arrow technique, review of some of the patients' target issues. Session 5: Developing awareness of underlying beliefs, strengthening positive self-talk, using behavioral techniques to replace positive thoughts instead of negative thoughts. Session 6: Use of cognitive-behavioral techniques about daring, Problem Solving and Teaching Social Skills to Addicts Session 7: Identify more unconditional and nuclear beliefs, weaken unconditional beliefs by questioning them in a Socratic manner, and rate negative beliefs on a scale of 0 to 100. Session 8: Continued Generating and developing alternative positive beliefs through the development of social and communication skills, developing problem-solving skills and courageous behaviors, grading alternative thoughts, preparing to apply the methods learned in future life situations. Session 9: Skills training Communication, group discussion, supplementary activities, teaching effective verbal response style and active listening skills. Session 10: Teaching self-control and alertness skills, group discussion, providing complementary activities and post-test. Intervention 3: Control group:.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>No - There is not a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for not sharing IPD is Because of moral issues</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Mohammad Entezamimehr</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No. 47, Eighth floor, Industry building, Zahiralaslam St., Jomhory St, Tehran.</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1146835785</zip>
        <telephone>+98 21 3392 7727</telephone>
        <email>Email4m.mehr@gmail.com</email>
        <affiliation>Islamic azad university, arak branch</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Mohammad Entezamimehr</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No. 47, Eighth floor, Industry building, Zahiralaslam St., Jomhory St, Tehran.</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1146835785</zip>
        <telephone>+98 21 3392 7727</telephone>
        <email>Email4m.mehr@gmail.com</email>
        <affiliation>Islamic azad university, arak branch</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Completion of informed consent form, age range 20 to 40 years, opioid dependence, constant amount of medication (methadone, bo pro norphine, etc.) until the end of the project, having an up-cycle education, being right-handed</inclusion_criteria>
      <agemin>20 years</agemin>
      <agemax>40 years</agemax>
      <gender>Male</gender>
      <exclusion_criteria></exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
      <i_code>N/A</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Direct electrical stimulation period of the brain: twice a week on Sundays and Thursdays for 5 consecutive weeks as follows. How to hold meetings. The treatment plan will be the same in all 10 sessions of intervention in terms of type, severity and duration of stimulation. During the treatment sessions, the subject will sit on a comfortable chair, then according to the standard system of 10 to 20 electroencephalography reported by Jasper, points will be identified on the subject's head and the anode electrode on the lateral dorsal lateral cortex and the cathode electrode on the lateral dorsal cortex. His right forehead will be placed and applied with a pair of sponge electrodes measuring 3.5 cm of direct current generated by a current of 2 mA with 30 seconds of up and down for 20 minutes. During the stimulation, the subject sits on a chair and does not perform a specific task.</i_keyword>
      <i_keyword>Group cognitive-behavioral therapy will be based on Beck theory's cognitive-behavioral therapy. This intervention will be taught in 10 sessions as follows: Session 1: initial acquaintance and establishing a therapeutic relationship, raising the main complaints of women, brief introduction of the type of treatment, collaborating with the research sample in determining the goals of the treatment protocol, determining the relationship between cognition, Emotion and behavior, choosing goals and identifying goals and agreeing on homework, recording life events. Session 2: Formulation of general problems of addicts in the form of cognitive-behavioral model, integration of cognitive triangle in treatment strategies, use of standard behavioral activation techniques , Redesigning negative spontaneous thoughts and presenting dysfunctional thoughts record sheet. Session 3: Continuing to work with spontaneous thoughts, examining patients' dysfunctional thoughts record sheets, challenging spontaneous thoughts by Socrates method. Session 4: Recognizing underlying beliefs and how to activate them in situations Specifically, the use of downward arrow technique, review of some of the patients' target issues. Session 5: Developing awareness of underlying beliefs, strengthening positive self-talk, using behavioral techniques to replace positive thoughts instead of negative thoughts. Session 6: Use of cognitive-behavioral techniques about daring, Problem Solving and Teaching Social Skills to Addicts Session 7: Identify more unconditional and nuclear beliefs, weaken unconditional beliefs by questioning them in a Socratic manner, and rate negative beliefs on a scale of 0 to 100. Session 8: Continued Generating and developing alternative positive beliefs through the development of social and communication skills, developing problem-solving skills and courageous behaviors, grading alternative thoughts, preparing to apply the methods learned in future life situations. Session 9: Skills training Communication, group discussion, supplementary activities, teaching effective verbal response style and active listening skills. Session 10: Teaching self-control and alertness skills, group discussion, providing complementary activities and post-test.</i_keyword>
      <i_keyword>Control group:</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Direct electrical stimulation of the brain, Cognitive-behavioral therapy. Timepoint: 3 month. Method of measurement: Therapeutic intervention of electrical stimulation of the brain, cognitive-behavioral therapy protocol.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Islamic azad university, Arak branch</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2022-05-21</approval_date>
        <contact_name>Research Ethics Committees of Islamic Azad University- Arak Branch</contact_name>
        <contact_address>No. 47, Eighth floor, Industry building, Zahiralaslam St., Jomhory St, Tehran. Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
